Journal
NATURE BIOTECHNOLOGY
Volume 23, Issue 12, Pages 1517-1526Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt1171
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA107268] Funding Source: Medline
- NIBIB NIH HHS [R01 EB002047, EB 002047] Funding Source: Medline
- NIGMS NIH HHS [GM 65361] Funding Source: Medline
Ask authors/readers for more resources
Dendrimers are branched, synthetic polymers with layered architectures that show promise in several biomedical applications. By regulating dendrimer synthesis, it is possible to precisely manipulate both their molecular weight and chemical composition, thereby allowing predictable tuning of their biocompatibility and pharmacokinetics. Advances in our understanding of the role of molecular weight and architecture on the in vivo behavior of dendrimers, together with recent progress in the design of biodegradable chemistries, has enabled the application of these branched polymers as anti-viral drugs, tissue repair scaffolds, targeted carriers of chemotherapeutics and optical oxygen sensors. Before such products can reach the market, however, the field must not only address the cost of manufacture and quality control of pharmaceutical-grade materials, but also assess the long-term human and environmental health consequences of dendrimer exposure in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available